Comprehensive Cancer Center Leadership

John D. Carpten, Ph.D., is uniquely positioned to help further City of Hope’s critical goal of democratizing cancer care and expanding access to leading-edge research and care for more patients, families and communities.
Steven T. Rosen, M.D., is a professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, and executive vice president and director emeritus, Comprehensive Cancer Center and Beckman Research Institute of City of Hope.

Kimlin Tam Ashing, Ph.D., is a professor and directs the Center of Community Alliance for Research & Education at City of Hope. She is a notable leader in examining cancer disparities and quality of life. Her life's work is to increase the voice and representation of underrepresented groups in
Marwan G. Fakih, M.D., is a medical oncologist specializing in gastrointestinal cancers.

Ajay Goel, Ph.D., AGAF, associate director of basic science, comprehensive cancer center; professor and chair, Department of Molecular Diagnostics and Experimental Therapeutics, researches molecular pathogenesis of human gastrointestinal cancers and its relationship to early detection of cancer

Larry Kwak, M.D., Ph.D., is the director of the Toni Stephenson Lymphoma Center at City of Hope.

Ashley Baker Lee is Senior Vice President of Research Operations at City of Hope, overseeing clinical and basic research operations and providing administrative leadership for Beckman Research Institute.

Listed numerous times as one of America’s Castle Connolly Top Doctors®, Joanne Mortimer, M.D., is the Baum Family Professor in Women’s Cancers. She takes a special interest in examining how hormones affect normal and tumor cells.

Victoria Seewaldt, M.D., is the Ruth Ziegler Chair in Population Sciences and chair and professor of the Department of Population Sciences, with a clinical specialty in breast cancer.

John Termini, Ph.D., is Associate Director of Shared Resources at City of Hope's comprehensive cancer center. He is also a professor of molecular medicine.

Nagarajan Vaidehi, Ph.D., is a scientist, educator and leader with a career-long commitment to developing computational methods to simulate dynamics of proteins involved in signal transduction pathways and using them for the discovery of next generation drugs with lower side effects. Dr. Vaidehi is